Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial The French CCS Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback